Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field

scientific article published on 13 October 2016

Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field is …
instance of (P31):
meta-analysisQ815382
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EURONEURO.2016.09.641
P698PubMed publication ID27745932

P50authorLars Vedel KessingQ27504786
Kamilla Woznica MiskowiakQ46998797
P2093author name stringC V Ott
J Z Petersen
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectsystematic reviewQ1504425
cognitive dysfunctionQ57859955
P304page(s)1845-1867
P577publication date2016-10-13
P1433published inEuropean NeuropsychopharmacologyQ15286536
P1476titleSystematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field
P478volume26

Reverse relations

cites work (P2860)
Q58573474Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review
Q64922479Cognitive impairment in depression: recent advances and novel treatments.
Q47659984Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression
Q47852885Could EPO studies improve mood disorder treatment strategies?
Q57817628Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?-A Perspective Paper
Q41310518Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`.
Q58609028Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
Q57477426GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?
Q91352773Neuronal underpinnings of cognitive impairment and - improvement in mood disorders
Q89782948Relations entre dépression et troubles cognitifs
Q124708287Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction
Q33697903The 'cognitive footprint' of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort.
Q47713553The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
Q98195629Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
Q59800555Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0

Search more.